<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathog Dis</journal-id><journal-id journal-id-type="iso-abbrev">Pathog Dis</journal-id><journal-id journal-id-type="pmc-domain-id">2716</journal-id><journal-id journal-id-type="pmc-domain">pathdis</journal-id><journal-id journal-id-type="publisher-id">femspd</journal-id><journal-title-group><journal-title>Pathogens and Disease</journal-title></journal-title-group><issn pub-type="epub">2049-632X</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5808651</article-id><article-id pub-id-type="pmcid-ver">PMC5808651.1</article-id><article-id pub-id-type="pmcaid">5808651</article-id><article-id pub-id-type="pmcaiid">5808651</article-id><article-id pub-id-type="pmid">28873944</article-id><article-id pub-id-type="doi">10.1093/femspd/ftx094</article-id><article-id pub-id-type="publisher-id">ftx094</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Protective efficacy by various doses of a new brucellosis vaccine candidate based on <italic toggle="yes">Salmonella</italic> strains expressing <italic toggle="yes">Brucella abortus</italic> BSCP31, Omp3b and superoxide dismutase against brucellosis in murine model</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="WK">Won Kyong</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Moon</surname><given-names initials="JY">Ja Young</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cho</surname><given-names initials="JS">Jeong Sang</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hur</surname><given-names initials="J">Jin</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1">Veterinary Public Health, College of Veterinary Medicine, Chonbuk National University Iksan Campus, Iksan 54596, South Korea</aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> Veterinary Public Health, College of Veterinary Medicine, Chonbuk National University Iksan Campus, Iksan 54596, South Korea. Tel: +82-63-850-0959; Fax: +82-63-850-0910; E-mail: <email>hurjin@jbnu.ac.kr</email></corresp></author-notes><pub-date pub-type="epub" iso-8601-date="2017-07-29"><day>29</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2017</year></pub-date><volume>75</volume><issue>7</issue><issue-id pub-id-type="pmc-issue-id">306517</issue-id><elocation-id>ftx094</elocation-id><history><date date-type="accepted"><day>28</day><month>7</month><year>2017</year></date><date date-type="received"><day>04</day><month>6</month><year>2017</year></date></history><pub-history><event event-type="pmc-release"><date><day>29</day><month>07</month><year>2017</year></date></event><event event-type="pmc-live"><date><day>15</day><month>02</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2018-03-27 01:22:32.953"><day>27</day><month>03</month><year>2018</year></date></event></pub-history><permissions><copyright-statement>&#169; FEMS 2017.</copyright-statement><copyright-year>2017</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ftx094.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ftx094.pdf"/><abstract><title>Abstract</title><p>
<italic toggle="yes">Brucella</italic> species are important etiological agents of zoonotic diseases. Attenuated <italic toggle="yes">Salmonella</italic> strains expressing <italic toggle="yes">Brucella abortus</italic> BCSP31, Omp3b and superoxide dismutase proteins were tested as vaccine candidates in this study. In order to determine the optimal dose for intraperitoneal (IP) inoculation required to obtain effective protection against brucellosis, mice were immunized with various doses of a mixture of the three vaccine strains<italic toggle="yes">.</italic> Fifty BALB/c mice were divided into five equal groups (groups A&#8211;E). Group A mice were intraperitoneally inoculated with 100 &#956;L of sterile phosphate-buffered saline. Group B, C, D and E mice were intraperitoneally immunized with approximately 1.2 &#215; 10<sup>5</sup> colony-forming units (CFU) mL<sup>&#8722;1</sup> of <italic toggle="yes">Salmonella</italic> containing pMMP65 in 100 &#956;L and with 1.2 &#215; 10<sup>4</sup> CFU mL<sup>&#8722;1</sup>, 1.2 &#215; 10<sup>5</sup> CFU mL<sup>&#8722;1</sup> and 1.2 &#215; 10<sup>6</sup> CFU mL<sup>&#8722;1</sup> of the mixture of the three strains in 100 &#956;L, respectively. Serum IgG, tumor necrosis factor alpha and interferon gamma concentrations were significantly higher in group E than in groups A&#8211;D. Following challenge with <italic toggle="yes">B. abortus</italic> 544, the challenge strain was not detected in the spleen of any mouse from group E. Thus, IP immunization with 1.2 &#215; 10<sup>6</sup> CFU mL<sup>&#8722;1</sup> of the mixture of the three vaccine strains induced immune responses and provided effective protection against brucellosis in mice.</p></abstract><abstract abstract-type="teaser"><p>This report suggests that intraperitoneal immunization with the mixture of the delivery strains can effectively protect mice against brucellosis.</p></abstract><kwd-group kwd-group-type="keywords"><kwd><italic toggle="yes">Brucella abortus</italic></kwd><kwd>brucellosis</kwd><kwd>immunization</kwd><kwd>public health</kwd><kwd>attenuated <italic toggle="yes">Salmonella</italic> Typhimurium</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><named-content content-type="funder-name">National Research Foundation of Korea</named-content><named-content content-type="funder-identifier">10.13039/501100003725</named-content></funding-source><award-id>2013R1A4A1069486</award-id></award-group></funding-group><counts><page-count count="6"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>INTRODUCTION</title><p>
<italic toggle="yes">Brucella</italic> species are important etiological agents of zoonotic diseases (Avila-Calderon <italic toggle="yes">et&#160;al.</italic><xref rid="bib2" ref-type="bibr">2013</xref>; Olsen <xref rid="bib20" ref-type="bibr">2013</xref>). Brucellosis is caused by <italic toggle="yes">Brucella</italic> and leads to abortion in domestic ruminants, thereby making it a major concern. <italic toggle="yes">Brucella</italic> is a facultative intracellular pathogen, which invades and multiplies intracellularly in macrophages within the host system (Bowden <italic toggle="yes">et&#160;al.</italic><xref rid="bib4" ref-type="bibr">1995</xref>; Baldwin and Goenka <xref rid="bib3" ref-type="bibr">2006</xref>). Humoral and cell-mediated immune responses can change the course of <italic toggle="yes">Brucella</italic> infection but cell-mediated immune responses are necessary to clear <italic toggle="yes">Brucella</italic> from the host organism (Schurig, Sriranganathan and Corbel <xref rid="bib23" ref-type="bibr">2002</xref>). In particular, the Th1-type immune response mediated by interferon gamma (IFN-&#947;) helps to combat <italic toggle="yes">Brucella</italic> infections (Zhan, Kelso and Cheers <xref rid="bib30" ref-type="bibr">1993</xref>). Strong Th2-type humoral immune responses, such as those involving serum IgG, are also necessary for protection against infection with intracellular pathogens (Roesler <italic toggle="yes">et&#160;al.</italic><xref rid="bib22" ref-type="bibr">2006</xref>; Brumme <italic toggle="yes">et&#160;al.</italic><xref rid="bib9" ref-type="bibr">2007</xref>; Adone <italic toggle="yes">et&#160;al.</italic><xref rid="bib1" ref-type="bibr">2012</xref>) because systemic antibodies eliminate pathogens from the blood and promote their phagocytosis by opsonization (Mastroeni <italic toggle="yes">et&#160;al.</italic><xref rid="bib19" ref-type="bibr">2001</xref>; Brumme <italic toggle="yes">et&#160;al.</italic><xref rid="bib9" ref-type="bibr">2007</xref>). Many vaccines have been designed to combat brucellosis, but the commercially available vaccines comprise live and attenuated <italic toggle="yes">Brucella</italic> strains. Notably, these strains can revert into pathogenic strains and may also interfere with the diagnosis (Avila-Calderon <italic toggle="yes">et&#160;al.</italic><xref rid="bib2" ref-type="bibr">2013</xref>; Olsen <xref rid="bib20" ref-type="bibr">2013</xref>). Because of these limita-tions, there is an urgent need for better and safer vaccines.</p><p>Live attenuated <italic toggle="yes">Salmonella</italic> strains have been proposed as a useful vector for carrying protective antigens of other pathogens (Hur and Lee <xref rid="bib15" ref-type="bibr">2011</xref>; Hur, Byeon and Lee <xref rid="bib14" ref-type="bibr">2014</xref>). The gastrointestinal tract is the entry portal common for both <italic toggle="yes">Brucella</italic> and <italic toggle="yes">Salmonella</italic>. Furthermore, most <italic toggle="yes">Salmonella</italic> vaccine strains retain a limited ability to invade the internal lymphoid organs, and thus, adequate induction of cell-mediated immunity can be expected (Martinoli, Chiavelli and Rescigno <xref rid="bib18" ref-type="bibr">2007</xref>).</p><p>Recombinant proteins of <italic toggle="yes">Brucella abortus</italic> may be suitable vaccine candidates because they can never cause infections and the adjuvant or immunization route employed to obtain antigen-specific immune responses can also be modified (Zhao <italic toggle="yes">et&#160;al.</italic><xref rid="bib32" ref-type="bibr">2009</xref>). Reportedly, a protein purified from strain 19 designated as the cell surface 31-kDa protein (or BCSP31) can serve as a protective subunit vaccine in rodents (Tabatabai and Deyoe <xref rid="bib25" ref-type="bibr">1983</xref>; Tabatabai, Deyoe and Patterson <xref rid="bib24" ref-type="bibr">1989</xref>). BCSP31 is either a glycosylated protein or may have a tight association with a <italic toggle="yes">Brucella</italic> polysaccharide moiety (Bricker <italic toggle="yes">et&#160;al.</italic><xref rid="bib7" ref-type="bibr">1988</xref>). Outer membrane proteins (Omps) are the protective antigens of <italic toggle="yes">Brucella</italic> species (Verstreate <italic toggle="yes">et&#160;al.</italic><xref rid="bib28" ref-type="bibr">1982</xref>). Omp3b, also known as Omp22, belongs to group 3 of the <italic toggle="yes">Brucella</italic> Omps (Vizcaino <italic toggle="yes">et&#160;al.</italic><xref rid="bib29" ref-type="bibr">2004</xref>), which is a highly conserved family comprising up to seven members, including some of the most abundant and immunogenic <italic toggle="yes">Brucella</italic> proteins (Cloeckaert <italic toggle="yes">et&#160;al.</italic><xref rid="bib12" ref-type="bibr">2002</xref>). The <italic toggle="yes">sodC</italic> gene encodes a Cu/Zn superoxide dismutase (SOD), which catalyzes the dismutation of oxygen radicals (Bricker <italic toggle="yes">et&#160;al.</italic><xref rid="bib8" ref-type="bibr">1990</xref>). SOD might act as a virulence factor by scavenging harmful oxygen radicals produced during phagocytosis by macrophages (Tabatabai and Pugh <xref rid="bib26" ref-type="bibr">1994</xref>).</p><p>In a previous study (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>), <italic toggle="yes">Salmonella</italic> Typhimurium strains expressing the BCSP31, Omp3b and SOD proteins of <italic toggle="yes">B. abortus</italic> were used as vaccine candidates to determine the optimal inoculation route in a murine model. Intraperitoneal (IP) immunization with a mixture of the <italic toggle="yes">Salmonella</italic> strains induced adequate immune responses and provided effective protection against brucellosis in mice. The present study aimed to determine the optimal dose for IP immunization using a mixture of the <italic toggle="yes">Salmonella</italic> strains to achieve protection against brucellosis in a murine model. The humoral immune responses and protective efficacy obtained after IP inoculation with various doses of the mixture of three vaccine strains were studied in mice. Mice intraperitoneally inoculated with the <italic toggle="yes">Salmonella</italic>-based <italic toggle="yes">Brucella</italic> vaccine candidate exhibited robust humoral and cell-mediated immune responses, thereby yielding effective protection against virulent <italic toggle="yes">B. abortus</italic>.</p></sec><sec sec-type="methods" id="sec2"><title>MATERIALS AND METHODS</title><sec id="sec2-1"><title>Animals and ethics statement</title><p>Fifty 5-week-old female BALB/c mice were distributed into five equal groups (groups A&#8211;E). All mice were maintained according to the previously described method (Hur and Lee <xref rid="bib15" ref-type="bibr">2011</xref>). All animal experiments performed in this study received ethical approval (CBU 2015-052) from the Chonbuk National University Animal Ethics Committee in accordance with the guidelines of the Korean council on Animal Care.</p></sec><sec id="sec2-2"><title>Bacterial strains, plasmids and growth conditions</title><p>Attenuated <italic toggle="yes">Salmonella</italic> vector-mediated strains for delivering the recombinant BCSP31, Omp3b and SOD antigens, which have been constructed and used as vaccine strains in the previous study, were used as vaccine candidates in the present study (Table&#160;<xref ref-type="table" rid="tbl1">1</xref>) (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>). <italic toggle="yes">Brucella abortus</italic> strain 544 (HJL254) was used as the virulent challenge strain (Lee <italic toggle="yes">et&#160;al.</italic><xref rid="bib17" ref-type="bibr">2014</xref>). <italic toggle="yes">Escherichia coli</italic> BL21(DE3) bacteria were used as host cells for overexpressing the recombinant BCSP31, Omp3b and SOD antigens. pET28a and pET32a plasmids were used as vectors for overexpressing the individual antigens. Except for <italic toggle="yes">B. abortus</italic> strain 544, all strains were grown in Luria-Bertani broth (LB; Becton, Dickinson and Company, Sparks, MD, USA) or on LB agar. <italic toggle="yes">Brucella abortus</italic> strain 544 was grown on Brucella agar (Becton, Dickinson and Company, Sparks, MD, USA). All strains were cultured at&#160;37&#176;C.</p><table-wrap id="tbl1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Bacterial strains and plasmids used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1">Strain/plasmid</th><th align="left" rowspan="1" colspan="1">Description</th><th align="left" rowspan="1" colspan="1">Source</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Strains</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BL21(DE3)</td><td align="left" rowspan="1" colspan="1">F<sup>&#8211;</sup>, <italic toggle="yes">omp</italic>T, <italic toggle="yes">hsd</italic>S<sub>B</sub>(r<sub>B</sub><sup>&#8211;</sup>,m<sub>B</sub><sup>&#8211;</sup>), <italic toggle="yes">dcm, gal</italic>, &#955;(DE3)</td><td align="left" rowspan="1" colspan="1">Lab stock</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL206</td><td align="left" rowspan="1" colspan="1">BL21 with pET32a-BCSP31</td><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL204</td><td align="left" rowspan="1" colspan="1">BL21 with pET28a-Omp3b</td><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL208</td><td align="left" rowspan="1" colspan="1">BL21 with pET28a-SOD</td><td align="left" rowspan="1" colspan="1">This study</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic toggle="yes">Salmonella</italic> Typhimurium</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">JOL401</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Salmonella</italic> Typhimurium wild type</td><td align="left" rowspan="1" colspan="1">Lab stock</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">JOL911</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">S. Typhimurium</italic> JOL401derivave <italic toggle="yes">&#916;lon&#916;cpxR</italic></td><td align="left" rowspan="1" colspan="1">Lab stock</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">JOL912</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">S</italic>. Typhimurium JOL911 derivative <italic toggle="yes">&#916;asd</italic></td><td align="left" rowspan="1" colspan="1">[20]</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL229</td><td align="left" rowspan="1" colspan="1">JOL912 with pMMP65</td><td align="left" rowspan="1" colspan="1">[21]</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL228</td><td align="left" rowspan="1" colspan="1">JOL912 with pMMP65-BCSP31</td><td align="left" rowspan="1" colspan="1">[21]</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL219</td><td align="left" rowspan="1" colspan="1">JOL912 with pMMP65-Omp3b</td><td align="left" rowspan="1" colspan="1">[21]</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">HJL213</td><td align="left" rowspan="1" colspan="1">JOL912 with pMMP65-SOD</td><td align="left" rowspan="1" colspan="1">[21]</td></tr><tr><td align="left" colspan="2" rowspan="1">
<italic toggle="yes">Brucella abortus</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Biotype 1</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">B. abortus</italic> biotype 1 isolate from cow in Korea</td><td align="left" rowspan="1" colspan="1">Lab stock</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Strain 544</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Brucella abortus</italic> strain 544 (ATCC23448)</td><td align="left" rowspan="1" colspan="1">[20]</td></tr><tr><td align="left" colspan="2" rowspan="1">Plasmids</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">pET28a</td><td align="left" rowspan="1" colspan="1">IPTG-inducible expression vector; Km<sup>r</sup></td><td align="left" rowspan="1" colspan="1">Novagen</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">pET32a</td><td align="left" rowspan="1" colspan="1">IPTG-inducible expression vector; Amp<sup>r</sup></td><td align="left" rowspan="1" colspan="1">Novagen</td></tr><tr><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">pMMP65</td><td align="left" rowspan="1" colspan="1">Asd<sup>+</sup>, pBR <italic toggle="yes">ori</italic>, &#946;-lactamase signal sequence-based periplasmic secretion plasmid, 6&#215; His tag</td><td align="left" rowspan="1" colspan="1">[21]</td></tr></tbody></table></table-wrap></sec><sec id="sec2-3"><title>Preparation of individual recombinant proteins</title><p>The overexpressed recombinant proteins comprising BCSP31 from HJL906, Omp31 from HJL904 and SOD from HJL908 have been conducted and used in a previous study (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>). The recombinant proteins were also used as coating antigens for an enzyme-linked immunosorbent assay (ELISA) and as re-stimulating proteins for splenocytes in the present study.</p></sec><sec id="sec2-4"><title>Preparation of <italic toggle="yes">Salmonella</italic> delivery strain formulation</title><p>The previously described vaccine candidate strains comprising HJL228, HJL219 and HJL213 were also used as vaccine candidates in the present study (Table&#160;<xref ref-type="table" rid="tbl1">1</xref>) (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>).</p></sec><sec id="sec2-5"><title>Immunization of mice and sample collection</title><p>Fifty 5-week-old female BALB/c mice were divided into five equal groups (n = 10 mice per group). All mice were immunized at 6 weeks of age. Group A mice were intraperitoneally inoculated with 100 &#956;L of sterile phosphate-buffered saline (PBS) as the control. Group B mice were intraperitoneally immunized with approximately 1.2 &#215; 10<sup>5</sup> colony-forming units (CFU) mL<sup>&#8722;1</sup> of HJL229 in 100 &#956;L as the vector control. Groups C, D and E mice were intraperitoneally immunized with approximately 1.2 &#215; 10<sup>4</sup> CFU mL<sup>&#8722;1</sup>, 1.2 &#215; 10<sup>5</sup> CFU mL<sup>&#8722;1</sup> and 1.2 &#215; 10<sup>6</sup> CFU mL<sup>&#8722;1</sup> of a mixture (equal CFU counts of each strain) of the three delivery strains in 100 &#956;L, respectively. Blood samples were collected before immunization [0 weeks post-immunization (WPI)] and again at 3 WPI to evaluate the serum IgG levels. All samples were stored at &#8722;70&#176;C until use.</p></sec><sec id="sec2-6"><title>Immune response measurement by ELISA</title><p>Standard ELISA was performed to evaluate the immune responses against the BCSP31, Omp3b and SOD antigens in serum samples obtained from mice according to the previously described method (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>). The ELISA results are expressed as mean &#177; standard deviation.</p></sec><sec id="sec2-7"><title>Collection of cytokines from splenocytes</title><p>At 3 WPI, five mice from each group were sacrificed and their spleens were aseptically removed. Single-cell suspensions were obtained by homogenizing the spleens. Splenocytes were collected by centrifugation at 1000 rpm for 5 min. Red blood cells were lysed with 0.9% NH<sub>4</sub>Cl and then subjected to three washes with complete RPMI medium to remove NH<sub>4</sub>Cl. Spleen cells were checked for viability using the Trypan blue exclusion method and were seeded into 24-well tissue culture plates at 2 &#215; 10<sup>6</sup> cells per well (Velikovsky <italic toggle="yes">et&#160;al.</italic><xref rid="bib27" ref-type="bibr">2003</xref>). Splenocytes were stimulated <italic toggle="yes">in vitro</italic> using BCSP31, Omp3b and SOD antigens (4 &#956;g well<sup>&#8722;1</sup>), with concanavalin A (0.5 &#956;g well<sup>&#8722;1</sup>) as the positive control or media as the unstimulated control, and incubated at 37&#176;C under 5% CO<sub>2</sub> and 95% humidity (Adone <italic toggle="yes">et&#160;al.</italic><xref rid="bib1" ref-type="bibr">2012</xref>). Supernatants were collected from the media after restimulation for 48 h and were stored at &#8722;70&#176;C until use for quantifying cytokines (Adone <italic toggle="yes">et&#160;al.</italic><xref rid="bib1" ref-type="bibr">2012</xref>).</p></sec><sec id="sec2-8"><title>Measurement of cytokines by ELISA</title><p>ELISA was employed to measure the concentrations of cytokines, including IFN-&#947; and tumor necrosis factor alpha (TNF-&#945;), in the supernatants using a mouse cytokine ELISA Ready-SET-GO reagent set according to the manufacturer's instructions (eBioscience Inc., San Diego, CA, USA).</p></sec><sec id="sec2-9"><title>Challenge experiments</title><p>Strain 544 was prepared for use in the challenge experiments. Briefly, the strain was grown in <italic toggle="yes">Brucella</italic> broth at 37&#176;C for 24 h and then resuspended to obtain approximately 1 &#215; 10<sup>5</sup> CFU mL<sup>&#8722;1</sup>. Five mice from each group were intraperitoneally challenged at 3 WPI with 100 &#956;L of the challenge strain. Two weeks after the challenge, spleen weights were measured and the numbers of viable strain 544 cells in the spleens were counted (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>). Vaccine and challenge strains were confirmed by polymerase chain reaction (PCR) using the <italic toggle="yes">B. abortus</italic>-specific primer (5&#900;-GACGAACGGAATTTTTCCAATCCC-3&#900;) and IS<italic toggle="yes">711</italic>-specific primer (5&#900;-TGCCGATCACTTAAGGGCCTTCAT-3&#900;) described in previous study (Bricker and Halling <xref rid="bib5" ref-type="bibr">1994</xref>, <xref rid="bib6" ref-type="bibr">1995</xref>).</p></sec><sec id="sec2-10"><title>Statistical analysis</title><p>CFU data were normalized by log transformation and evaluated by one-way analysis of variance, followed by Dunnett's post-hoc test using GraphPad software (GraphPad Software, Inc., La Jolla, CA, USA). The cellular responses were compared between the groups using one-way analysis of variance and Tukey's Multiple Comparisons test. The analyses were performed with SPSS version 16.0 software (SPSS, Chicago, IL, USA). The antibody responses were compared between the groups using two-way matching by rows (RM) analysis of variance and matching by rows test. The analyses were performed with SPSS version 16.0 software (SPSS, Chicago, IL, USA).</p></sec></sec><sec sec-type="results" id="sec3"><title>RESULTS</title><sec id="sec3-1"><title>Humoral immune responses in the vaccinated mice</title><p>The antibody responses against each antigen in the sera are shown in Fig.&#160;<xref ref-type="fig" rid="fig1">1</xref>. Serum IgG concentrations against all antigens were significantly higher in groups D and E than in the control group (<italic toggle="yes">P</italic> &#8804; 0.05). In addition, serum IgG concentrations against the individual antigens were significantly higher in group E than in groups B, C and D (<italic toggle="yes">P</italic> &#8804; 0.05) (Fig.&#160;<xref ref-type="fig" rid="fig1">1</xref>).</p><fig id="fig1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Antibody responses (ng mL<sup>&#8722;1</sup>) against BCSP31, Omp3b and SOD antigens. Group A mice were inoculated with sterile phosphate-buffered saline as a control. Group B mice were immunized with <italic toggle="yes">Salmonella Typhimurium</italic> containing pMMP65 only as a vector control. Group C, D and E mice were inoculated with approximately 1.2 &#215; 10<sup>4</sup> CFU mL<sup>&#8722;1</sup>, 1.2 &#215; 10<sup>5</sup> CFU mL<sup>&#8722;1</sup> and 1.2 &#215; 10<sup>6</sup> CFU mL<sup>&#8722;1</sup> of the mixture of the three delivery strains in 100 &#956;L, respectively. Data represent the means of all mice in each group, and error bars represent the standard deviations. * <italic toggle="yes">P</italic> &lt; 0.05 vs Group A; # <italic toggle="yes">P</italic> &lt; 0.05 vs Group B; &#182; <italic toggle="yes">P</italic> &lt; 0.05 vs Group C; &#167; <italic toggle="yes">P</italic> &lt; 0.05 vs Group D.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ftx094fig1.jpg"/></fig></sec><sec id="sec3-2"><title>Cytokine analysis</title><p>TNF-&#945; and IFN-&#947; concentrations in splenocytes in response to BCSP31, Omp31 and SOD after re-stimulation with the individual antigens were measured using ELISA at 3 WPI. TNF-&#945; concentrations were significantly higher in groups C, D and E than in groups A and B (<italic toggle="yes">P</italic> &lt; 0.05) (Fig.&#160;<xref ref-type="fig" rid="fig2">2</xref>). In addition, compared with group C, TNF-&#945; concentrations in response to all antigens in groups D and E were significantly increased. IFN-&#947; concentrations in response to all antigens were also significantly higher in groups D and E than in groups A and B. In addition, compared with group C, IFN-&#947; concentrations in response to all antigens were significantly increased in group E (<italic toggle="yes">P</italic> &lt; 0.05) (Fig.&#160;<xref ref-type="fig" rid="fig2">2</xref>).</p><fig id="fig2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Cytokine concentrations (pg mL<sup>&#8722;1</sup>) in splenocytes at 3 WPI. Groups A, B, C, D and E are indicated as in Fig.&#160;<xref ref-type="fig" rid="fig1">1</xref>. Data represent the means of all mice in each group, and error bars indicate the standard deviations. * <italic toggle="yes">P</italic> &lt; 0.05 vs Group A; # <italic toggle="yes">P</italic> &lt; 0.05 vs Group B; &#182; <italic toggle="yes">P</italic> &lt; 0.05 vs Group C; &#167; <italic toggle="yes">P</italic> &lt; 0.05 vs Group D.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ftx094fig2.jpg"/></fig></sec><sec id="sec3-3"><title>Protection of mice against virulent challenge</title><p>Five mice from each group were intraperitoneally challenged with approximately 4 &#215; 10<sup>4</sup> CFU of the challenge strain at 3 WPI. Fourteen days after the challenge, the infection level was evaluated by determining the CFU counts in the spleens. As shown in Fig.&#160;<xref ref-type="fig" rid="fig3">3</xref>, group D and E mice exhibited significantly greater protection than group A, B and C mice. The challenge strain was isolated from all group A, B and C mice. By contrast, the challenge strain was isolated from only two-fifth of the group D mice and wild-type <italic toggle="yes">Brucella abortus</italic> was not detected in the spleen of any group E mouse.</p><fig id="fig3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Bacterial proliferation in the spleens of mice challenged with wild-type <italic toggle="yes">Brucella abortus</italic> strain 544. Groups A, B, C, D and E are indicated as in Fig.&#160;<xref ref-type="fig" rid="fig1">1</xref>. All mice in each group were intraperitoneally challenged with 1 &#215; 10<sup>4</sup> CFU of virulent wild-type <italic toggle="yes">B. abortus</italic> 544 at 3 WPI. The numbers of viable bacteria recovered from the spleens of mice on day 14 post-challenge are shown. The lines represent the means (n = 5 mice per group). * <italic toggle="yes">P</italic> &lt; 0.05 vs Group A; # <italic toggle="yes">P</italic> &lt; 0.05 vs Group B; &#182; <italic toggle="yes">P</italic> &lt; 0.05 vs Group C; &#167; <italic toggle="yes">P</italic> &lt; 0.05 vs Group D.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ftx094fig3.jpg"/></fig></sec></sec><sec sec-type="discussion" id="sec4"><title>DISCUSSION</title><p>Brucellosis is a globally distributed zoonotic disease, which causes severe detrimental effects to health and economic losses in endemic areas (Carvalho Neta <italic toggle="yes">et&#160;al.</italic><xref rid="bib10" ref-type="bibr">2010</xref>). <italic toggle="yes">Brucella abortus</italic> is a facultative intracellular bacterium that can invade hosts through the mucosa and survive inside phagocytes by evading the endocytic pathway. The gastrointestinal tract is one of the major entry portals for <italic toggle="yes">B. abortus</italic> (Gorvel, Moreno and Moriyon <xref rid="bib13" ref-type="bibr">2009</xref>). The resistance of hosts to <italic toggle="yes">Brucella</italic> infection mainly depends on mucosal immunity and acquired cell-mediated immunity. The two main components of the host protective systemic immune responses are CD4<sup>+</sup> T lymphocytes and CD8<sup>+</sup> T lymphocytes secreting IFN-&#947; and the lysis of <italic toggle="yes">Brucella</italic>-infected cells (Paranavitana <italic toggle="yes">et&#160;al.</italic><xref rid="bib21" ref-type="bibr">2005</xref>).</p><p>Attenuated <italic toggle="yes">Salmonella</italic> has many advantages as a vector for carrying protective <italic toggle="yes">Brucella</italic> antigens; these include the delivery of the antigen to the host, a simple preparation procedure and convenient inoculation (Chen and Schifferli <xref rid="bib11" ref-type="bibr">2003</xref>; Hur, Byeon and Lee <xref rid="bib14" ref-type="bibr">2014</xref>). In the present study, attenuated <italic toggle="yes">Salmonella</italic> Typhimurium host cells and the pMMP65 plasmid delivery system were used to deliver <italic toggle="yes">B. abortus</italic> BCSP31, Omp3b and SOD antigens, as described in a previous study (Kim <italic toggle="yes">et&#160;al.</italic><xref rid="bib16" ref-type="bibr">2016</xref>). Mice were immunized with three different doses of a mixture of the <italic toggle="yes">Salmonella</italic>-based <italic toggle="yes">Brucella</italic> vaccine candidates. Compared with control group mice, group D (immunized with approximately 1 &#215; 10<sup>5</sup> CFU) and E (immunized with approximately 1 &#215; 10<sup>6</sup> CFU) mice produced significantly higher amounts of serum IgG in response to the three antigens. In addition, serum IgG concentrations in group E were significantly higher than those in groups B (immunized with the <italic toggle="yes">Salmonella</italic> containing vector only), C (immunized with approximately 1 &#215; 10<sup>4</sup> CFU) and D (immunized with approximately 1 &#215; 10<sup>5</sup> CFU). However, serum IgG concentrations in group B were only slightly higher than those in the control group. Thus, IP immunization with approximately 1.0 &#215; 10<sup>6</sup> CFU significantly induced a protective IgG response.</p><p>The Th1-type immune response is considered to be desirable for protection against brucellosis (Zhan, Liu and Cheers <xref rid="bib31" ref-type="bibr">1996</xref>; Baldwin and Goenka <xref rid="bib3" ref-type="bibr">2006</xref>). The role of TNF-&#945; in controlling <italic toggle="yes">Brucella</italic> infection in mice is important because of the activation of macrophages, which are responsible for killing <italic toggle="yes">Brucella</italic> in the absence of IFN-&#947; (Zhan, Liu and Cheers <xref rid="bib31" ref-type="bibr">1996</xref>). IFN-&#947; plays a crucial role in combating <italic toggle="yes">Brucella</italic> infection because of its ability to activate the antibacterial functions of infected macrophages (Paranavitana <italic toggle="yes">et&#160;al.</italic><xref rid="bib21" ref-type="bibr">2005</xref>; Baldwin and Goenka <xref rid="bib3" ref-type="bibr">2006</xref>). In this study, we investigated the cell-mediated immune response generated by IP immunization with <italic toggle="yes">Salmonella</italic> vaccine candidates expressing <italic toggle="yes">B. abortus</italic> BSCP31, Omp3b and SOD antigens. Cytokine concentrations were evaluated in the supernatants obtained from the splenocytes of mice immunized with the vaccine candidates after re-stimulation with the heat-inactivated <italic toggle="yes">B. abortus</italic> whole antigens. TNF-&#945; and IFN-&#947; concentrations were significantly higher in groups D and E than in groups A (immunization with PBS) and B (immunization with <italic toggle="yes">Salmonella</italic> containing pBP244 only). These results indicated that IP immunization with approximately 1 &#215; 10<sup>5</sup> CFU of the mixture of <italic toggle="yes">Salmonella</italic> vaccine candidates could induce strong Th1-type immune responses. Furthermore, significantly higher IFN-&#947; and TNF-&#945; concentrations were found in the culture supernatants of splenocytes obtained from group E mice than in those obtained from group C. Thus, it is logical to conclude that IFN-&#947; produced by IP immunization with approximately 1 &#215; 10<sup>6</sup> CFU of the mixture might have contributed to the increased protection in this group.</p><p>A major difficulty that has prevented the development of a vaccine against <italic toggle="yes">Brucella</italic> is the lack of the definite proof of efficient protection. We found that group C, D and E mice exhibited significantly greater protection than group A and B mice, demonstrating that IP immunization with the <italic toggle="yes">Salmonella</italic> vaccine candidates could protect mice from infection with the virulent <italic toggle="yes">B. abortus</italic> strain 544. Furthermore, group E mice exhibited the best protection against infection with the virulent <italic toggle="yes">B. abortus</italic> strain 544. It is possible that IP immunization with approximately 1 &#215; 10<sup>6</sup> CFU of the <italic toggle="yes">Salmonella</italic> mixture made larger amounts of antigens available to antigen-presenting cells, which induced the strongest mucosal and cell-mediated immune responses.</p><p>In summary, the results of this study demonstrated that IP immunization with approximately 1 &#215; 10<sup>6</sup> CFU of <italic toggle="yes">Salmonella</italic>-based <italic toggle="yes">Brucella</italic> vaccine induced robust antibody and cell-mediated immune responses in mice. The vaccine conferred protection against infection with <italic toggle="yes">B. abortus</italic>, which was comparable to that by immunization with approximately 1 &#215; 10<sup>6</sup> CFU of the <italic toggle="yes">Salmonella</italic>-based <italic toggle="yes">Brucella</italic> vaccine. Thus, we suggest that IP immunization with approximately 1 &#215; 10<sup>6</sup> CFU of the <italic toggle="yes">Salmonella</italic> mixture is a good candidate for vaccine development to combat brucellosis.</p></sec></body><back><sec id="sec5"><title>FUNDING</title><p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MISP) (No. 2013R1A4A1069486).</p><p>
<bold><italic toggle="yes">Conflict of interest</italic>.</bold> None declared.</p></sec><ref-list><title>REFERENCES</title><ref id="bib1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adone</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Francia</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pistoia</surname><given-names>C</given-names></name><etal/></person-group><article-title>Protective role of antibodies induced by <italic toggle="yes">Brucella melitensis</italic> B115 against <italic toggle="yes">B. melitensis</italic> and <italic toggle="yes">Brucella abortus</italic> infections in mice</article-title>. <source>Vaccine</source><year>2012</year>;<volume>30</volume>:<fpage>3992</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">22521283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2012.04.009</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Calderon</surname><given-names>ED</given-names></name>, <name name-style="western"><surname>Lopez-Merino</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name><etal/></person-group><article-title>A history of the development of <italic toggle="yes">Brucella</italic> vaccines</article-title>. <source>Biomed Res Int</source><year>2013</year>;<volume>2013</volume>:<fpage>743509</fpage>.<pub-id pub-id-type="pmid">23862154</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2013/743509</pub-id><pub-id pub-id-type="pmcid">PMC3686056</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldwin</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Goenka</surname><given-names>R</given-names></name></person-group><article-title>Host immune responses to the intracellular bacteria <italic toggle="yes">Brucella</italic>: does the bacteria instruct the host to facilitate chronic infection?</article-title><source>Crit Rev Immunol</source><year>2006</year>;<volume>26</volume>:<fpage>407</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">17341186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1615/critrevimmunol.v26.i5.30</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Zygmunt</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Surface exposure of outer membrane protein and lipopolysaccharide epitopes in <italic toggle="yes">Brucella</italic> species studied by enzyme-linked immunosorbent assay and flow cytometry</article-title>. <source>Infect Immun</source><year>1995</year>;<volume>63</volume>:<fpage>3945</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">7558303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.63.10.3945-3952.1995</pub-id><pub-id pub-id-type="pmcid">PMC173554</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bricker</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Halling</surname><given-names>SM</given-names></name></person-group><article-title>Differentiation of <italic toggle="yes">Brucella abortus</italic> bv. 1, 2, and 4, <italic toggle="yes">Brucella melitensis, Brucella ovis</italic>, and <italic toggle="yes">Brucella suis</italic> bv. 1 by PCR</article-title>. <source>J Clin Microbiol</source><year>1994</year>;<volume>32</volume>:<fpage>2660</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">7852552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.32.11.2660-2666.1994</pub-id><pub-id pub-id-type="pmcid">PMC264138</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bricker</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Halling</surname><given-names>SM</given-names></name></person-group><article-title>Enhancement of the <italic toggle="yes">Brucella</italic> AMOS PCR assay for differentiation of <italic toggle="yes">Brucella abortus</italic> vaccine strains S19 and RB51</article-title>. <source>J Clin Microbiol</source><year>1995</year>;<volume>33</volume>:<fpage>1640</fpage>&#8211;<lpage>2</lpage>.<pub-id pub-id-type="pmid">7650203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.33.6.1640-1642.1995</pub-id><pub-id pub-id-type="pmcid">PMC228233</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bricker</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Deyoe</surname><given-names>BL</given-names></name><etal/></person-group><article-title>Conservation of antigenicity in a 31-kDa <italic toggle="yes">Brucella</italic> protein</article-title>. <source>Vet Microbiol</source><year>1988</year>;<volume>18</volume>:<fpage>313</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">3148240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(88)90096-x</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bricker</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Judge</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Cloning, expression, and occurrence of the <italic toggle="yes">Brucella</italic> Cu-Zn superoxide dismutase</article-title>. <source>Infect Immun</source><year>1990</year>;<volume>58</volume>:<fpage>2935</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2201639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.58.9.2935-2939.1990</pub-id><pub-id pub-id-type="pmcid">PMC313590</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brumme</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sigmarsson</surname><given-names>H</given-names></name><etal/></person-group><article-title>Impact of <italic toggle="yes">Salmonella</italic> Typhimurium DT104 virulence factors invC and sseD on the onset, clinical course, colonization patterns and immune response of porcine salmonellosis</article-title>. <source>Vet Microbiol</source><year>2007</year>;<volume>124</volume>:<fpage>274</fpage>&#8211;<lpage>85</lpage>.<pub-id pub-id-type="pmid">17524577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vetmic.2007.04.032</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carvalho Neta</surname><given-names>AV</given-names></name>, <name name-style="western"><surname>Mol</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Xavier</surname><given-names>MN</given-names></name><etal/></person-group><article-title>Pathogenesis of bovine brucellosis</article-title>. <source>Vet J</source><year>2010</year>;<volume>184</volume>:<fpage>146</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="pmid">19733101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tvjl.2009.04.010</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Schifferli</surname><given-names>DM</given-names></name></person-group><article-title>Construction, characterization, and immunogenicity of an attenuated <italic toggle="yes">Salmonella enterica</italic> serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter</article-title>. <source>Infect Immun</source><year>2003</year>;<volume>71</volume>:<fpage>4664</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">12874347</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.8.4664-4673.2003</pub-id><pub-id pub-id-type="pmcid">PMC165986</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vizcaino</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Paquet</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Major outer membrane proteins of <italic toggle="yes">Brucella</italic> spp.: past, present and future</article-title>. <source>Vet Microbiol</source><year>2002</year>;<volume>90</volume>:<fpage>229</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">12414146</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00211-0</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gorvel</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Moreno</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Moriyon</surname><given-names>I</given-names></name></person-group><article-title>Is <italic toggle="yes">Brucella</italic> an enteric pathogen?</article-title><source>Nat Rev Microbiol</source><year>2009</year>;<volume>7</volume>:<fpage>250</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro2012-c1</pub-id><pub-id pub-id-type="pmid">19172149</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Byeon</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Immunologic study and optimization of <italic toggle="yes">Salmonella</italic> delivery strains expressing adhesin and toxin antigens for protection against progressive atrophic rhinitis in a murine model</article-title>. <source>Can J Vet Res</source><year>2014</year>;<volume>78</volume>:<fpage>297</fpage>&#8211;<lpage>303</lpage>.<pub-id pub-id-type="pmid">25355999</pub-id><pub-id pub-id-type="pmcid">PMC4170769</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hur</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name></person-group><article-title>Immune responses to new vaccine candidates constructed by a live attenuated <italic toggle="yes">Salmonella</italic> Typhimurium delivery system expressing <italic toggle="yes">Escherichia coli</italic> F4, F5, F6, F41 and intimin adhesin antigens in a murine model</article-title>. <source>J Vet Med Sci</source><year>2011</year>;<volume>73</volume>:<fpage>1265</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">21628866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1292/jvms.11-0087</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>WW</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><article-title>Comparison between immunization routes of live attenuated <italic toggle="yes">Salmonella</italic> Typhimurium strain expressing BCSP31, Omp3b, and SOD of <italic toggle="yes">Brucella abortus</italic> in murine model</article-title>. <source>Fron Microbiol</source><year>2016</year>;<volume>7</volume>:<fpage>550</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2016.00550</pub-id><pub-id pub-id-type="pmcid">PMC4837157</pub-id><pub-id pub-id-type="pmid">27148232</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Characterization of culture supernatant proteins from <italic toggle="yes">Brucella abortus</italic> and its protection effects against murine brucellosis</article-title>. <source>Comp Immunol Microbiol Infect Dis</source><year>2014</year>;<volume>37</volume>:<fpage>221</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25016407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cimid.2014.06.001</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martinoli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chiavelli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Rescigno</surname><given-names>M</given-names></name></person-group><article-title>Entry route of <italic toggle="yes">Salmonella typhimurium</italic> directs the type of induced immune response</article-title>. <source>Immunity</source><year>2007</year>;<volume>27</volume>:<fpage>975</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="pmid">18083577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2007.10.011</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mastroeni</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chabalgoity</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Dunstan</surname><given-names>SJ</given-names></name><etal/></person-group><article-title><italic toggle="yes">Salmonella</italic>: immune responses and vaccines</article-title>. <source>Vet J</source><year>2001</year>;<volume>161</volume>:<fpage>132</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">11243685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/tvjl.2000.0502</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olsen</surname><given-names>SC</given-names></name></person-group><article-title>Recent developments in livestock and wildlife brucellosis vaccination</article-title>. <source>Rev Sci Tech</source><year>2013</year>;<volume>32</volume>:<fpage>207</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="pmid">23837378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.20506/rst.32.1.2201</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paranavitana</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Zelazowska</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Izadjoo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Interferon-gamma associated cytokines and chemokines produced by spleen cells from <italic toggle="yes">Brucella</italic>-immune mice</article-title>. <source>Cytokine</source><year>2005</year>;<volume>30</volume>:<fpage>86</fpage>&#8211;<lpage>92</lpage>.<pub-id pub-id-type="pmid">15804600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cyto.2004.12.009</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roesler</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Heller</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Waldmann</surname><given-names>KH</given-names></name><etal/></person-group><article-title>Immunization of sows in an integrated pig-breeding herd using a homologous inactivated <italic toggle="yes">Salmonella</italic> vaccine decreases the prevalence of <italic toggle="yes">Salmonella typhimurium</italic> infection in the offspring</article-title>. <source>J Vet Med B Infect Dis Vet Public Health</source><year>2006</year>;<volume>53</volume>:<fpage>224</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16732880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1439-0450.2006.00951.x</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schurig</surname><given-names>GG</given-names></name>, <name name-style="western"><surname>Sriranganathan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Corbel</surname><given-names>MJ</given-names></name></person-group><article-title>Brucellosis vaccines: past, present and future</article-title>. <source>Vet Microbiol</source><year>2002</year>;<volume>90</volume>:<fpage>479</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="pmid">12414166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0378-1135(02)00255-9</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Deyoe</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>JM</given-names></name></person-group><article-title>Immunogenicity of <italic toggle="yes">Brucella abortus</italic> salt-extractable proteins</article-title>. <source>Vet Microbiol</source><year>1989</year>;<volume>20</volume>:<fpage>49</fpage>&#8211;<lpage>58</lpage>.<pub-id pub-id-type="pmid">2503922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-1135(89)90006-0</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Deyoe</surname><given-names>BL</given-names></name></person-group><article-title>Isolation of two biologically active cell surface proteins from <italic toggle="yes">Brucella abortus</italic> by chromatofocusing</article-title>. <source>Fed Proc</source><year>1983</year>;<volume>42</volume>:<fpage>2127</fpage></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabatabai</surname><given-names>LB</given-names></name>, <name name-style="western"><surname>Pugh</surname><given-names>GW</given-names><suffix>Jr</suffix></name></person-group><article-title>Modulation of immune responses in Balb/c mice vaccinated with <italic toggle="yes">Brucella abortus</italic> Cu-Zn superoxide dismutase synthetic peptide vaccine</article-title>. <source>Vaccine</source><year>1994</year>;<volume>12</volume>:<fpage>919</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="pmid">7526568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0264-410x(94)90035-3</pub-id></mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velikovsky</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Goldbaum</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Cassataro</surname><given-names>J</given-names></name><etal/></person-group><article-title><italic toggle="yes">Brucella</italic> lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with <italic toggle="yes">Brucella abortus</italic> 544 independently of the adjuvant formulation used</article-title>. <source>Infect Immun</source><year>2003</year>;<volume>71</volume>:<fpage>5750</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">14500496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.71.10.5750-5755.2003</pub-id><pub-id pub-id-type="pmcid">PMC201088</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verstreate</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Creasy</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Caveney</surname><given-names>NT</given-names></name><etal/></person-group><article-title>Outer membrane proteins of <italic toggle="yes">Brucella abortus</italic>: isolation and characterization</article-title>. <source>Infect Immun</source><year>1982</year>;<volume>35</volume>:<fpage>979</fpage>&#8211;<lpage>89</lpage>.<pub-id pub-id-type="pmid">6802764</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.35.3.979-989.1982</pub-id><pub-id pub-id-type="pmcid">PMC351144</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vizcaino</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Caro-Hernandez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Cloeckaert</surname><given-names>A</given-names></name><etal/></person-group><article-title>DNA polymorphism in the omp25/omp31 family of <italic toggle="yes">Brucella</italic> spp.: identification of a 1.7-kb inversion in <italic toggle="yes">Brucella cetacea</italic> and of a 15.1-kb genomic island, absent from <italic toggle="yes">Brucella ovis</italic>, related to the synthesis of smooth lipopolysaccharide</article-title>. <source>Microbes Infect</source><year>2004</year>;<volume>6</volume>:<fpage>821</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">15374004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micinf.2004.04.009</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kelso</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Cheers</surname><given-names>C</given-names></name></person-group><article-title>Cytokine production in the murine response to <italic toggle="yes">Brucella</italic> infection or immunization with antigenic extracts</article-title>. <source>Immunology</source><year>1993</year>;<volume>80</volume>:<fpage>458</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">8288319</pub-id><pub-id pub-id-type="pmcid">PMC1422217</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Cheers</surname><given-names>C</given-names></name></person-group><article-title>Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium <italic toggle="yes">Brucella abortus</italic> by different mechanisms</article-title>. <source>Infect Immun</source><year>1996</year>;<volume>64</volume>:<fpage>2782</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">8698508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.64.7.2782-2786.1996</pub-id><pub-id pub-id-type="pmcid">PMC174139</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Protection of mice from <italic toggle="yes">Brucella</italic> infection by immunization with attenuated <italic toggle="yes">Salmonella enterica</italic> serovar typhimurium expressing A L7/L12 and BLS fusion antigen of <italic toggle="yes">Brucella</italic></article-title>. <source>Vaccine</source><year>2009</year>;<volume>27</volume>:<fpage>5214</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19596411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.vaccine.2009.06.075</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>